$FORM

STEVEN-WAISS KELLEY sold $202K of FORM

STEVEN-WAISS KELLEY sold 2,100 shares of FORMFACTOR INC (FORM) at $96.10 ($0.20M total) on 2026-09-03.

Original reporting
SEC EDGAR · STEVEN-WAISS KELLEY
Published Sep 4, 2026, 8:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 9:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$FORM
Neutral
high confidence
Mentioned
$FORM
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FORMNeutralLow
01

Why it matters

The disclosed sale is modest in size and unlikely to affect market perception significantly.

02

Market read

Primary relevance is to FORM shareholders; no broader market implications.

03

What to watch

Kelley's remaining stake of 24,426 shares still aligns his interests with shareholders.

Relevance 4/10Novelty 4/10Timing: post-market 2026-09-04

Background

FormFactor Inc (NASDAQ: FORM) filed a Form 4 reporting a director's sale of 2,100 shares at $96.10 per share.

Company-level read

Ticker impact

$FORMNeutralHigh confidence
Context

Director Steven-Waiss Kelley sold 2,100 shares of FormFactor Inc for $201,810, reducing his holdings to 24,426 shares.

Expected impact

Minimal short-term price pressure; unlikely to move the stock materially.

Evidence & confidence

The transaction amount is under $1M and represents a small fraction of total float, typical for routine portfolio rebalancing.

Market effects

No broader sector impact; insider activity is company‑specific.

None; the filing is U.S.‑listed and does not affect regional markets.

Low; limited to FormFactor investors.

Counterpoint

The sale could be a routine liquidity move rather than a negative signal; the stock may remain stable.

Key entities

  • FormFactor Inc

    U.S. listed provider of test and measurement solutions.

  • Steven-Waiss Kelley

    Board member of FormFactor who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FORMMed

Stifel reiterates FormFactor stock rating after Teradyne deal

Stifel kept a Hold rating and $115 price target on FormFactor (FORM) after Teradyne (TER) agreed to a $300M equity stake, pending approval. FORM shares are down 7.8% this week but up 223% year-over-year. Q2 earnings beat estimates with $0.82 EPS and $258.2M revenue. Deutsche Bank initiated coverage with a Buy rating and $200 target, citing Nvidia and TSMC opportunities.

$FORMHighAI 8/10

FormFactor and Teradyne announce collaboration, $300M investment

FormFactor (FORM) and Teradyne (TER) announced a collaboration and $300M investment in semiconductor test and measurement technologies. The deal aims to combine FormFactor's probe technologies with Teradyne's automated test platforms, focusing on high-performance compute and advanced packaging applications. The transaction is subject to regulatory approvals.